Creation of new businesses with a scale of ¥5 billion to ¥10 billion by the mid-2030s
First written in FY2025. 1 of 4 entries say "Restated". Latest entry: 2026-08-06.
103 other companies' latest entry also says "Advanced".
- 2026-08-06AdvancedEarnings presentation
「2027年度の販売を目指し、PR活動を推進」
細胞培養容器について、展示会出展、情報発信、サンプルワーク拡大を進め、販売開始に向けた活動を具体化している。 - FY2026ReframedAnnual report
「In semiconductor-related operations, we will develop new chemical solutions in response to customer needs, further enhance the functionality of cell-culture vessels and inorganic fluoride nanoparticles currently under development, and advance application development. In addition, we will work to establish a flow-synthesis method incorporating our proprietary fluorine technologies and focus on developing high-value-added products using this method.」
While maintaining its target of creating new businesses worth ¥5 billion to ¥10 billion by the mid-2030s, the company has specified development themes including new chemical solutions, cell-culture vessels, inorganic fluoride nanoparticles and flow-synthesis methods. - 2026-05-28RestatedGeneral Meetings of Shareholders
「フッ素化学を基礎とする独自技術を活かした研究開発の推進により、2030年代半ばを目標に新規事業の創出に取り組んでまいります。」
2030年代半ばを目標とする新規事業創出の期限と手段を継続している。 - FY2025First statedAnnual report
「Through research and development based on its proprietary fluorine chemistry technologies, the company will work to create new businesses worth ¥5 billion to ¥10 billion, targeting the mid-2030s.」
The company has set a target of creating new businesses worth ¥5 billion to ¥10 billion by the mid-2030s and identified research and development leveraging its proprietary technologies as the means of achieving it.